Subsequently, downregulation of UBE2M exhibited a shorter half-life for β-catenin in the CHX chase assay, suggesting that UBE2M increases β-catenin protein stability in HCC cells (Figure 4B and 4C). The gene discussed is UBE2M; the disease is hepatocellular carcinoma.